Heart Disease Trial, Recruiting (NCT07671742)

Heart Disease Trial, Recruiting NCT07671742 Sponsor: Acorai AB Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07671742 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are 18 years of age or older
People who have been admitted to hospital primarily because of heart failure, meaning they have new or worsening heart failure symptoms with signs of fluid buildup in the body that require starting or increasing heart failure treatment
People who are able to sign a written consent form agreeing to take part

Who may not be able to join:

People whose participation is considered by the trial team to carry potential risks to their health or safety, or who may be unable to follow the study requirements
People who are pregnant or breastfeeding (as reported by the person or confirmed through medical records)
People who have a skin rash or open wound on the area of the body where the study device (the Acorai Device model 1.0) would be placed
People with any other health condition that the trial doctor believes would prevent safe participation or could affect the reliability of the study results (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 9 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +46 709 72 60 97

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07671742

Sponsor: Acorai AB

Phase: Not Applicable

Status: Recruiting

Condition: Heart Disease

Trial contact: +46 709 72 60 97

More information: https://clinicaltrials.gov/study/NCT07671742

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are 18 years of age or older
People who have been admitted to hospital primarily because of heart failure, meaning they have new or worsening heart failure symptoms with signs of fluid buildup in the body that require starting or increasing heart failure treatment
People who are able to sign a written consent form agreeing to take part

Who may not be able to join:

People whose participation is considered by the trial team to carry potential risks to their health or safety, or who may be unable to follow the study requirements
People who are pregnant or breastfeeding (as reported by the person or confirmed through medical records)
People who have a skin rash or open wound on the area of the body where the study device (the Acorai Device model 1.0) would be placed
People with any other health condition that the trial doctor believes would prevent safe participation or could affect the reliability of the study results (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 9 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Acorai AB

Registry

ClinicalTrials.gov

Start date

1 April 2026

Est. completion

1 March 2027

Where this trial is recruiting

🇸🇪 Sweden

Primary endpoints

Composite of 90-Day Heart Failure Hospitalization or All-Cause Mortality

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov